Odyssey Therapeutics raised $279M through its IPO, exceeding expectations. The company, led by Gary Glick, starts trading on Nasdaq under 'ODTX'.
Amount Raised
$279 Million
Round Type
IPO
MedfieldBiotechnologyHealth CareInvestors
Description
Odyssey Therapeutics has successfully completed its IPO, raising $279 million by selling 15.5 million shares at $18 each. The offering exceeded initial expectations and marks a significant milestone for the biotech company. In addition to the IPO, Odyssey secured an additional $25 million through a concurrent private stock sale. Led by Gary Glick, Odyssey focuses on developing medicines for autoimmune disorders.
Quick answer
Odyssey Therapeutics, Inc. raised $279 Million in a IPO round, dated May 8, 2026. Investors: Orbimed and SR One. Odyssey Therapeutics, Inc. is based in Medfield, Massachusetts, United States.
- How much did Odyssey Therapeutics, Inc. raise?
- Odyssey Therapeutics, Inc. raised $279 Million in a IPO round on May 8, 2026.
- Who invested in Odyssey Therapeutics, Inc?
- Orbimed and SR One are named as investors in this round.
- What does Odyssey Therapeutics, Inc. do?
- Odyssey Therapeutics is a biotechnology company pioneering the efficient development of next generation immunomodulators and oncology medicines.
- Where is Odyssey Therapeutics, Inc. based and how big is it?
- Odyssey Therapeutics, Inc. is based in Medfield, Massachusetts, United States.
Source: Fundz verified event record.
Who else raised in Biotechnology and Health Care around the same time
Companies in the same sectors as Odyssey Therapeutics, Inc. that raised within 45 days of this round, from Fundz verified event records.
- Innovide raised $9.8M (Series B) on June 22, 2026.
- Lys Therapeutics raised $28M (Grant) on June 22, 2026.
- Graph Therapeutics raised $5M (Funding Round) on June 22, 2026.
- Bionyra Pharma raised $165M (Series A) on June 22, 2026.
- Bionyra raised $165M (Series A) on June 22, 2026.
- Syntax Bio raised $14M (Series A) on June 21, 2026.
Who to call at Odyssey Therapeutics, Inc., and when
A new round usually means Odyssey Therapeutics, Inc. is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Odyssey Therapeutics, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Odyssey Therapeutics, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Odyssey Therapeutics, Inc.. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Odyssey Therapeutics, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Odyssey Therapeutics, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.